Silver Book Fact

Multifocal electroretinogram (mFERG) and flicker perimetry show abnormal function in the central macula in early ag-related macular degeneration (AMD) and could enhance monitoring of the disease progression in individuals.

Gin, Thomas J., Chi D. Luu, and Robyn H. Guymer. Central Retinal Function as Measured by the Multifocal Electroretinogram and Flicker Perimetry in AMD. Invest Opthalmol Vis Sci. 2011; 52(12): 9267-9274

Reference

Title
Central Retinal Function as Measured by the Multifocal Electroretinogram and Flicker Perimetry in AMD
Publication
Invest Opthalmol Vis Sci
Publication Date
2011
Authors
Gin, Thomas J., Chi D. Luu, and Robyn H. Guymer
Volume & Issue
Volume 52, Issue 12
Pages
9267-9274

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Nearly 50% of diabetic retinopathy patients who received ranibizumab–an anti-VEGF drug–experienced substantial visual improvement after a year of injections  
  • A study on the impact of diet on age-related macular degeneration (AMD) found that those who took the highest amounts of carotenoids, such as lutein and zeaxanthin, had a 43%…  
  • Of the 8 million older Americans at high risk of developing advanced age-related macular degeneration (AMD), 1.3 million will develop advanced AMD within 5 years. However, the NEI-sponsored Age-Related Eye…  
  • Screening and treatment for eye disease in all type 2 diabetes patients would result in an estimated net savings of 94,304 person-years of sight.  
  • Macugen to treat wet age-related macular degeneration (AMD)
    A new FDA-approved ophthalmic drug that treats wet age-related macular degeneration (AMD)– pegaptanib sodium (Macugen)– reduced vision loss in 70% of clinical trial patients.